fluconazole has been researched along with terbinafine in 201 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (1.99) | 18.7374 |
| 1990's | 35 (17.41) | 18.2507 |
| 2000's | 84 (41.79) | 29.6817 |
| 2010's | 57 (28.36) | 24.3611 |
| 2020's | 21 (10.45) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ji, H; Jiang, Q; Lü, J; Miao, Z; Sheng, C; Song, Y; Xu, H; Yao, J; Zhang, M; Zhang, W; Zhou, Y; Zhu, J | 1 |
| Berdicevsky, I; Eads, E; Heitman, J; Horwitz, BA; Kaufman, G; Onyewu, C; Perfect, JR; Schell, WA; Ullmann, Y | 1 |
| Cao, Y; Chen, J; Ji, H; Jiang, Y; Li, Y; Liang, R; Lü, J; Tang, H; Yao, B; Zheng, C; Zhou, Y; Zhu, J | 1 |
| Enriz, RD; Freile, M; Gupta, MP; Kouznetsov, VV; Sortino, M; Vargas Méndez, LY; Vásquez, Y; Zacchino, SA | 1 |
| Cano, J; Gené, J; Guarro, J; Marimon, R; Serena, C | 1 |
| Agarwal, AK; Ashfaq, MK; Babu, KS; Clark, AM; Elsohly, HN; Jacob, MR; Khan, SI; Li, XC; Manly, SP | 1 |
| Jiang, Y; Jin, Y; Li, P; Liu, P; Sun, P; Sun, Q; Wu, Q; Xie, W; Yang, X; Zhang, D; Zhang, Y; Zhu, S | 1 |
| Cannon, RD; Holmes, AR; Lamping, E; Nakamura, K; Niimi, K; Niimi, M; Ranchod, A; Tyndall, JD | 1 |
| Chai, X; Dan, Z; Hu, H; Jiang, Y; Sun, Q; Wu, Q; Yu, S; Zhang, J | 1 |
| Chai, X; Dan, Z; Hu, H; Wu, Q; Yu, S; Zhang, D; Zhang, J; Zhao, Q; Zou, Y | 1 |
| Gao, C; Pang, G; Sun, S; Wang, B; Xu, Y; Zhao, D; Zhou, L | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chai, X; Guan, Z; Hu, H; Sun, Q; Wu, Q; Yan, Y; Yu, S; Zou, Y | 1 |
| Ghosh, I; Manoharlal, R; Prakash, O; Prasad, R; Puri, N; Sharma, M | 1 |
| Afeltra, J; Moglioni, AG; Moltrasio, GY; Sarmiento, GP; Vitale, RG | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Juvonen, RO; Koskiranta, J; Ollakka, R; Rahnasto-Rilla, M; Raunio, H; Ritvanen, A; Salminen, KA; Tani, N; Wittekindt, C | 1 |
| Chothe, AS; Dudhe, PB; Gadhwe, S; Kathiravan, MK; Mukta, MS; Salake, AB; Watode, RP | 1 |
| Badshah, A; Flörke, U; Iqbal, J; Rauf, MK; Shahid, M; Shoaib, K; Talib, A; Zaib, S | 1 |
| Chai, X; Hu, H; Huang, T; Li, R; Li, X; Wu, M; Wu, Q; Yu, S; Zhao, Q; Zou, Y | 1 |
| Gerwick, WH; Kurtán, T; Liu, B; Mándi, A; Sun, P; Tang, H; Wang, ZW; Xu, DX; Zhang, W | 1 |
| Bardiot, D; Cammue, BP; Chaltin, P; Cos, P; De Brucker, K; Maes, L; Marchand, A; McNaughton, M; Peeters, A; Taborda, CP; Thevissen, K | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chang, WQ; Li, XB; Lou, HX; Wang, XN; Xie, F; Zhang, JZ; Zhang, M; Zhao, ZT; Zhou, YH; Zhu, RX | 1 |
| Eweis, M; Gomha, SM; Ouf, AS; Ouf, SA; Sharawy, IA | 1 |
| Dong, Y; Lei, K; Liu, M; Sun, B; Wang, J; Zhao, L | 1 |
| Han, H; Qi, XR; Shen, L; Tang, HF; Xu, QZ; Yang, WS; Yi, YH; Yuan, CH | 1 |
| Bahn, YS; Cheong, E; Choi, JW; Jang, BK; Kim, D; Kim, HJ; Kim, S; Lee, DG; Lee, JS; Lee, KT; Lee, MH; Lee, YR; Park, JH; Park, KD; Park, SJ; Seo, KJ; Yeon, SK | 1 |
| Lesher, JL | 2 |
| Back, DJ; Tjia, JF | 1 |
| Graybill, JR; Sharkey, PK | 1 |
| Dupont, B | 1 |
| Hay, RJ | 2 |
| Stevens, DA | 1 |
| Abruzzo, GK; Fromtling, RA; Giltinan, DM; Turnbull, TA | 1 |
| Wenig, JA | 1 |
| Hoeprich, PD | 1 |
| Leitner, I; Meingassner, JG; Mieth, H | 1 |
| Roberts, DT | 1 |
| Degreef, H | 1 |
| Phillips, P | 1 |
| Neuvonen, PJ; Olkkola, KT; Varhe, A | 1 |
| Odom, RB | 1 |
| Suarez, S | 1 |
| Barchiesi, F; Falconi Di Francesco, L; Scalise, G | 1 |
| Piérard, GE | 1 |
| Del Rosso, JQ | 1 |
| Hecker, D | 1 |
| Joseph, WS | 1 |
| Arzeni, D; Barchiesi, F; Compagnucci, P; Di Francesco, LF; Giacometti, A; Scalise, G | 1 |
| Friedlander, SF; Suarez, S | 2 |
| Seebacher, C | 2 |
| Amichai, B; Grunwald, MH | 1 |
| Elewski, BE | 1 |
| Friedlander, SF | 1 |
| Frieden, IJ; Howard, RM | 1 |
| Nishimoto, K | 1 |
| Gupta, AK; Katz, HI; Shear, NH | 1 |
| Arrese, JE; Piérard, GE; Piérard-Franchimont, C | 2 |
| Gupta, AK; Lambert, J | 1 |
| Elewski, B; Ghannoum, MA | 1 |
| Gupta, AK; Shear, NH | 1 |
| Havu, V; Heikkilä, H; Kuokkanen, K; Nuutinen, M; Rantanen, T; Saari, S; Stubb, S; Suhonen, R; Turjanmaa, K | 1 |
| Korting, HC; Niewerth, M | 1 |
| Katz, HI | 1 |
| Ghannoum, MA; Jessup, CJ; Ryder, NS | 1 |
| Bradley, MC; Elewski, BE; Ghannoum, MA; Isham, N; Leidich, S | 1 |
| Del Rosso, JQ; Gupta, AK | 1 |
| Gupta, AK; Summerbell, RC | 1 |
| Calderon, L; Clemons, KV; Howell, KJ; Irani, PR; Pappagianis, D; Sobel, RA; Sorensen, KN; Stevens, DA; Williams, PL | 1 |
| Rand, S | 1 |
| Smith, EB | 1 |
| Gupta, AK | 1 |
| Drake, L; Gupta, AK; Lambert, J; Shear, N; Yaniv, R | 1 |
| Bassler, M; Rodgers, P | 1 |
| Leitner, I; Ryder, NS | 1 |
| Czaika, V; Schmalreck, A; Schultze, W; Sterry, W; Tietz, HJ | 1 |
| Gregurek-Novak, T; Gupta, AK | 1 |
| Skelton, H; Smith, KJ; Welsh, M | 1 |
| Chen, BK; Friedlander, SF | 1 |
| Fothergill, AW; Gonzalez, G; Perea, S; Rinaldi, MG; Sutton, DA | 1 |
| Pekurinen, M; Salo, H | 1 |
| Akar, A; Arca, E; Gür, AR; Kurumlu, Z; Taştan, HB | 1 |
| Fukuda, T | 1 |
| Glad'ko, VV; Tarasenko, GN | 1 |
| Denning, DW; Moore, CB; Mosquera, J; Sharp, A; Warn, PA | 1 |
| Cuenca-Estrella, M; Mellado, E; Rodríguez-Tudela, JL | 1 |
| Abeck, D; Korting, HC; Möhrenschlager, M; Ring, J; Seidl, HP | 1 |
| Engelen, M; Rochette, F; Vanden Bossche, H | 1 |
| De Maubeuge, J; Kolivras, A; Lateur, N; Scheers, C; Song, M; Wiame, L | 1 |
| Bigby, M | 1 |
| Grooters, AM; Taboada, J | 1 |
| Gupta, AK; Ryder, JE | 1 |
| De Hoog, GS; Verweij, PE; Vitale, RG | 1 |
| Akula, I; Edlind, T; Jain, P | 1 |
| Chávez-Caballero, M; Claro, RM; Martín-Mazuelos, E; Pemán, J; Serrano-Martino, Mdel C; Valverde-Conde, A | 1 |
| Caretta, G; Gianni, C; Romano, C | 1 |
| Blodgett, AE; Buurman, ET; Carcanague, D; Hull, KG | 1 |
| Fernandez-Obregon, AC; Greer, DL; Wignall, FS; Wingfield, AB | 1 |
| Reinel, D | 1 |
| Chan, YC; Friedlander, SF | 1 |
| Gupta, AK; Johnson, AM; Ryder, JE | 1 |
| Carrillo-Muñoz, AJ; Casals, J; del Valle, O; Guardià, C; Guglietta, A; Palacín, C; Quindós, G; Rodríguez, V | 1 |
| Friedlander, SF; Roberts, BJ | 1 |
| Cantón, E; Espinel-Ingroff, A; Gobernado, M; Pemán, J; Viudes, A | 1 |
| Ji, HT; Miao, ZY; Sheng, CQ; Song, YL; Yang, S; Yao, JZ; Yu, JX; Zhang, M; Zhang, WN; Zhu, J | 1 |
| Batra, R; Gupta, AK; Kohli, Y | 1 |
| Ayangil, D; Cankaya, S; Ferahbaş, A; Koc, AN; Silici, S | 1 |
| Afonso, E; Candido, RC; Ferreira, JC; Krakhecke, AG | 1 |
| Crawford, F; Ferrari, J | 2 |
| Hiruma, M | 1 |
| Apitz-Castro, R; Ledezma, E | 1 |
| Tietz, HJ | 1 |
| Cano, J; Gené, J; Gilgado, F; Guarro, J; Serena, C | 1 |
| Alvarez, MS; Silverberg, NB | 1 |
| Barros, ME; Hamdan, JS; Santos, Dde A | 1 |
| Barros, MEDS; Hamdan, JS; Santos, DA | 1 |
| Cursino-Santos, JR; Martinez-Rossi, NM; Paião, FG; Peres, NT; Segato, F | 1 |
| Bonifaz, A; Fierro, L; Paredes, V | 1 |
| Chen, S; Li, J; Li, S; Liu, Z; Tu, Y; Wu, Y | 1 |
| de Assis Santos, D; Figueiredo, VT; Hamdan, JS; Resende, MA | 1 |
| Guilhermetti, E; Shinobu, CS; Svidzinski, TI; Takahachi, G | 1 |
| Korting, HC; Schmid-Wendtner, MH | 1 |
| Can, F; Demirbilek, M; Sarifakioglu, E; Seçkin, D | 1 |
| Chan, AK; Chang, CH; Kurth, T; Orav, JE; Young-Xu, Y | 1 |
| Ali, S; Forgie, SE; Graham, TA | 1 |
| Chen, SC; Sorrell, TC | 1 |
| Bergus, G; González, U; Jacobson, J; Martínez-Monzón, C; Seaton, T | 1 |
| Carrillo-Muñoz, AJ; Del Valle, O; Eraso, E; Ezkurra, PA; Giusiano, G; Guardia, C; Hernández-Molina, JM; Quindós, G; Santos, P; Tur-Tur, C | 1 |
| Li, L; Li, R; Luo, S; Sun, X; Wang, Z | 1 |
| Celik, AD; Kantarcioglu, S; Mert, A; Ozaras, R; Ozturk, R; Tabak, F | 1 |
| Budihardja, D; Freund, V; Mayser, P | 1 |
| Brown, SJ | 1 |
| Bueno, JG; Gallego, M; Martinez, C; Mesa, AC; Sanclemente, G; Zapata, B | 1 |
| Fick, J; Lindberg, RH; Tysklind, M | 1 |
| Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Amitai, Z; Kaliner, E; Kopel, E; Predescu, S; Sprecher, H; Volovik, I | 1 |
| Byekova, Y; Elewski, B; Hughey, L | 1 |
| Cafarchia, C; Figueredo, LA; Iatta, R; Montagna, MT; Otranto, D | 1 |
| Arora, P; Grover, C; Manchanda, V | 1 |
| Baird, R; Coleman, M; Currie, BJ; Davis, JS; Ellis, DH; Gordon, CL; Haran, G; Jeremiah, CJ; Mileva, M; Ward, A; Warren, LJ; Whiting, S | 1 |
| Conesa, A; Gebbia, M; Giaever, G; Heisler, LE; Jaime, MD; Lee, AY; Lopez-Llorca, LV; Nislow, C; Proctor, M; Westwood, JT | 1 |
| Alexis, A; Bhanusali, D; Coley, M; Silverberg, JI; Silverberg, NB | 1 |
| Guerra, CR; Ishida, K; Nucci, M; Rozental, S | 1 |
| Ahmed, S; de Hoog, GS; Feng, P; Klaassen, CH; Lai, W; Lu, C; Meis, JF; Najafzadeh, MJ; Sun, J; Xi, L | 1 |
| Ananiev, J; Cardoso, JC; Ginter-Hanselmayer, G; Guarneri, C; Gulubova, M; Hristova, R; Kanazawa, N; Martino, G; Nenoff, P; Nocheva, D; Penev, PK; Taneva, T; Tchernev, G; Zisova, LG | 1 |
| Helou, J; Maatouk, I; Moutran, R; Obeid, G | 1 |
| Czaika, VA; Lam, PA | 1 |
| de Sá, DC; Lamas, AP; Tosti, A | 1 |
| Alizadeh, F; Chong, PP; Karimi, G; Khodavandi, A; Vanda, NA | 1 |
| Huang, X; Li, D; Mylonakis, E; Xi, L | 1 |
| Badali, H; de Hoog, GS; Mashedi, O; Meis, JF; Mohammadi, R | 1 |
| Galletti, J; Grassi, FL; Kioshima-Cotica, ÉS; Negri, M; Svidzinski, TI | 1 |
| Arzeni, D; Barchiesi, F; Castelli, P; Cirioni, O; Conte, I; Giacometti, A; Kamysz, E; Kamysz, W; Morciano, A; Offidani, AM; Orsetti, E; Scalise, A; Silvestri, C; Simonetti, O; Staffolani, S | 1 |
| Pajaziti, L; Vasili, E | 1 |
| Borelli, C; Jäckel, A; Müller, J; Polak, A; Schaller, M; Seidl, HP | 1 |
| Rosen, T; Stein Gold, LF | 1 |
| Busso-Lopes, AF; Kamei, K; Lyra, L; Mikami, Y; Moretti, ML; Peron, IH; Reichert-Lima, F; Schreiber, AZ; Taguchi, H | 1 |
| Bennett, C; Chen, X; González, U; Hua, X; Jiang, X; Lin, X; Xue, S; Yang, M; Zhang, M | 1 |
| Andrade, ZM; Correia, MD; Dalbem, PT; de Oliveira Alves, K; de Oliveira, CF; Heidrich, D; Landell, MF; Pagani, DM; Paulino, GV; Scroferneker, ML; Silva, C; Valente, P | 1 |
| García-Romero, MT; Solís-Arias, MP | 1 |
| Han, X; Hu, Y; Huang, S; Liu, K; Lu, Y; Mao, Z; Wu, Z; Zhou, X | 1 |
| Balta, I; Oz, A; Oz, Y; Qoraan, I | 1 |
| Carvalho, AR; Fuentefria, AM; Kaiser, S; Lana, AJ; Moraes, RC; Ortega, GG; Pippi, B | 1 |
| Qian, F; Wei, X; Xia, J; Xu, W; Zhang, Z | 1 |
| Kodedová, M; Sychrová, H | 1 |
| Corrêa, C; Fuentefria, AM; Goldani, LZ; Heidrich, D; Rosa, PD; Scroferneker, ML; Vettorato, G | 1 |
| Siew, HH | 1 |
| Girkontaitė, I; Lastauskienė, E; Markovskaja, S; Novickij, J; Novickij, V; Paškevičius, A; Švedienė, J; Zinkevičienė, A | 1 |
| Chakrabarti, A; Dogra, S; Mushtaq, K; Narang, T; Paul, RA; Rudramurthy, SM; Shankarnarayan, SA; Shaw, D | 1 |
| Friedlander, SF; Gupta, AK; Mays, RR; Piguet, V; Piraccini, BM; Shear, NH; Tosti, A; Versteeg, SG | 1 |
| Lipner, SR; Scher, RK | 1 |
| Chan, JFW; Chan, KF; Cheung, M; Fung, KSC; Lai, CKC; Lau, ECL; Lau, SKP; Lee, CY; Li, X; Ng, RHY; Ngan, AHY; Tang, JYM; Tsang, CC; Woo, PCY | 1 |
| Bamimore, MA; Foley, KA; Gupta, AK; Piguet, V; Shear, NH; Stec, N | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Lopes, AI; Pintado, ME; Tavaria, FK | 1 |
| Aala, F; Badali, H; Barac, A; Daie Ghazvini, R; Fatahi, N; Ghaffari, M; Hashemi, SJ; Izadi, A; Khodavaisy, S; Rezaie, S; Salehi, Z; Taran, M | 1 |
| Gupta, AK; Piguet, V; Piraccini, BM; Shear, NH; Stec, N; Summerbell, RC; Tosti, A | 1 |
| Anchan, VN; Chandra, U; Singh, S; Tilak, R; Verma, P | 1 |
| Chen, R; Cui, Y; Li, S; Shi, Y; Song, Y; Yao, L; Zhao, L; Zhen, Y | 1 |
| Elewski, B | 1 |
| Mathachan, SR; Sardana, K | 1 |
| Cohen, BA; DiBiagio, JR; Goldenberg, NA; Le, TK; Woodard, AA | 1 |
| Do, TBT; Ha, TNT; Le, CC; Ngo, TMC; Nguyen, PV; Santona, A; Ton Nu, PA; Tran Thi, G; Vo, MT | 1 |
| Abastabar, M; Aghili, SR; Badali, H; Haghani, I; Hedayati, MT; Javidnia, J; Khojasteh, S; Meis, JF; Moazeni, M; Nargesi, S; Nosratabadi, M; Shabanzadeh, S; Shokohi, T; Zaedi, A | 1 |
| Heidrich, D; Jank, L; Milani, G; Pagani, DM; Scroferneker, ML; They, NH; Tormente, F; Valente, P | 1 |
| Cooper, EA; Gupta, AK; Hall, DC; Summerbell, RC; Venkataraman, M | 1 |
| Alexander, AB; Gai, JJ; Highland, MA; Horgan, MD; Innis, C; Liguori, BL; Norton, TM; Ossiboff, RJ; Pesavento, PA; Stacy, BA; Wellehan, JFX | 1 |
| Aguiar, ALR; da Silva, BN; de Aguiar Cordeiro, R; de Andrade, ARC; de Lima-Neto, RG; Lima, XTV; Maia, DCSC; Moura, SGB; Pereira, LMG; Portela, FVM; Reis, AT; Rocha, MFG; Sidrim, JJC | 1 |
| Amin Shahidi, M; Badiee, P; Ghasemi, F; Hashemi, J; Jafarian, H; Mohammadi, R; Najafzadeh, MJ; Shokohi, T | 1 |
| Benedict, K; Dulski, TM; Gold, JAW; Lipner, SR | 1 |
| Sabir, M; Uddin, F; Zeeshan, F | 1 |
68 review(s) available for fluconazole and terbinafine
| Article | Year |
|---|---|
The biology and chemistry of antifungal agents: a review.
Topics: Animals; Antifungal Agents; Azoles; Fungi; Humans; Imidazoles; Mycoses | 2012 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fungal infections and their management.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine; Triazoles | 1990 |
New oral treatments for dermatophytosis.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Fluconazole; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Triazoles | 1988 |
The systemic treatment of onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1995 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
Oral therapeutic agents in fungal nail disease.
Topics: Administration, Oral; Allylamine; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors; Treatment Outcome | 1994 |
Onychomycosis. Agents of choice.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Candidiasis, Cutaneous; Fluconazole; Foot Dermatoses; Griseofulvin; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1993 |
[New antifungal agents in the treatment of superficial dermatomycoses].
Topics: Administration, Topical; Antifungal Agents; Azoles; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine; Tolnaftate | 1993 |
New antifungal therapy for children.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Dermatomycoses; Drug Interactions; Fluconazole; Hair Diseases; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Current trends in onychomycosis therapy: a literature review.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Oral treatment options for onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Antifungal therapy in children: an update.
Topics: Antifungal Agents; Child; Dermatomycoses; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 1998 |
[Diagnosis, differential diagnosis and therapy of onychomycosis].
Topics: Administration, Topical; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1998 |
Adverse drug reactions of the new oral antifungal agents--terbinafine, fluconazole, and itraconazole.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 1998 |
Onychomycosis: pathogenesis, diagnosis, and management.
Topics: Adult; Antifungal Agents; Child; Diagnosis, Differential; Female; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Male; Nails; Naphthalenes; Onychomycosis; Terbinafine | 1998 |
Pediatric antifungal therapy.
Topics: Antifungal Agents; Child; Dermatomycoses; Drug Interactions; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Terbinafine | 1998 |
The evolving role of itraconazole, fluconazole and terbinafine in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 1999 |
Dermatophyte infections in children.
Topics: Antifungal Agents; Arthrodermataceae; Child; Child, Preschool; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Naphthalenes; Terbinafine; Tinea; Trichophyton | 1999 |
Oral therapy of common superficial fungal infections of the skin.
Topics: Administration, Oral; Antifungal Agents; Drug Administration Schedule; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea | 1999 |
[Antifungal drugs for pediatric use].
Topics: Adult; Antifungal Agents; Child; Fluconazole; Humans; Infant; Infant, Newborn; Itraconazole; Naphthalenes; Terbinafine | 1999 |
Drug interactions with itraconazole, fluconazole, and terbinafine and their management.
Topics: Animals; Antifungal Agents; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Risk Assessment; Terbinafine | 1999 |
Facing up to the diagnostic uncertainty and management of onychomycoses.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1999 |
Pharmacoeconomic analysis of the new oral antifungal agents used to treat toenail onychomycosis in the USA.
Topics: Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Economics, Pharmaceutical; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; United States | 1999 |
The new oral antifungal agents for onychomycosis of the toenails.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 1999 |
Drug interactions of the newer oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Contraindications; Drug Interactions; Fluconazole; Humans; Intestinal Absorption; Itraconazole; Naphthalenes; Terbinafine | 1999 |
An evaluation of intermittent therapies used to treat onychomycosis and other dermatomycoses with the oral antifungal agents.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Drug Administration Schedule; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2000 |
Tinea capitis.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Scalp; Terbinafine; Tinea Capitis | 2000 |
Overview: The treatment of dermatophytosis.
Topics: Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 2000 |
The treatment of dermatophytosis: safety considerations.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 2000 |
Pharmacoeconomic analysis of ciclopirox nail lacquer solution 8% and the new oral antifungal agents used to treat dermatophyte toe onychomycosis in the United States.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Ciclopirox; Costs and Cost Analysis; Drug Costs; Economics, Pharmaceutical; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Models, Economic; Naphthalenes; Onychomycosis; Pyridones; Randomized Controlled Trials as Topic; Terbinafine; United States | 2000 |
Treating onychomycosis.
Topics: Adult; Antifungal Agents; Child; Clinical Trials as Topic; Combined Modality Therapy; Diagnosis, Differential; Drug Costs; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Patient Education as Topic; Recurrence; Teaching Materials; Terbinafine; Treatment Failure | 2001 |
Tinea capitis update: a continuing conflict with an old adversary.
Topics: Antifungal Agents; Child; Child, Preschool; Drug Interactions; Drug Resistance, Fungal; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis; United States | 2001 |
A plea to bridge the gap between antifungals and the management of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2001 |
[Clinical relevance of mechanisms of antifungal drug resistance in filamentous fungi].
Topics: Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Azoles; Caspofungin; Drug Resistance, Fungal; Drug Resistance, Multiple; Echinocandins; Fluconazole; Fungi; Incidence; Itraconazole; Lipopeptides; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Polyenes; Spain; Terbinafine | 2002 |
[Tinea capitis. Therapeutic options in the post-griseofulvin era].
Topics: Antifungal Agents; Clinical Trials as Topic; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis; Treatment Outcome | 2002 |
Antifungal agents of use in animal health--chemical, biochemical and pharmacological aspects.
Topics: Animals; Antifungal Agents; Clotrimazole; Drug Resistance, Fungal; Econazole; Fluconazole; Flucytosine; Griseofulvin; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Naphthalenes; Natamycin; Nystatin; Terbinafine; Thiabendazole; Tolnaftate; Veterinary Drugs | 2003 |
Update on antifungal therapy.
Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antifungal Agents; Caspofungin; Cat Diseases; Cats; Dog Diseases; Dogs; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 2003 |
The use of oral antifungal agents to treat onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Interactions; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2003 |
New treatments for tinea capitis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Trichophyton | 2004 |
Cumulative meta-analysis of systemic antifungal agents for the treatment of onychomycosis.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Onychomycosis; Randomized Controlled Trials as Topic; Terbinafine; Treatment Outcome | 2004 |
Tinea capitis: a treatment update.
Topics: Antifungal Agents; Child; Dose-Response Relationship, Drug; Fluconazole; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Pediatrics; Terbinafine; Tinea Capitis; Treatment Outcome; Trichophyton | 2005 |
Fungal nail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2005 |
[Onychomycosis: recent progress in the epidemiology, diagnosis and treatment].
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Foot Dermatoses; Hand Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Risk Factors; Terbinafine | 2006 |
[Ajoene the main active compound of garlic (Allium sativum): a new antifungal agent].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antifungal Agents; Clinical Trials as Topic; Dermatomycoses; Disulfides; Fibrinolytic Agents; Fluconazole; Fungi; Garlic; Humans; Medicine, Traditional; Naphthalenes; Phytotherapy; Sulfinic Acids; Sulfoxides; Terbinafine; Tinea | 2006 |
Fungal toenail infections.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Onychomycosis; Terbinafine | 2006 |
Tinea capitis.
Topics: Antifungal Agents; Fluconazole; Global Health; Griseofulvin; Humans; Itraconazole; Microsporum; Naphthalenes; Terbinafine; Tinea Capitis; Trichosporon; United States | 2006 |
Effective treatment for dermatophytoses of the foot: effect on restoration of depressed cell-mediated immunity.
Topics: Animals; Antifungal Agents; Fluconazole; Foot Dermatoses; Humans; Immunity, Cellular; Itraconazole; Ketoconazole; Mycoses; Naphthalenes; Terbinafine | 2007 |
The safety of oral antifungal treatments for superficial dermatophytosis and onychomycosis: a meta-analysis.
Topics: Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Liver Function Tests; Models, Statistical; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Risk Assessment; Terbinafine; Transaminases | 2007 |
The assessment and management of tinea capitis in children.
Topics: Antifungal Agents; Child; Diagnosis, Differential; Fluconazole; Griseofulvin; Humans; Incidence; Itraconazole; Naphthalenes; Terbinafine; Tinea Capitis | 2007 |
Antifungal agents.
Topics: Antifungal Agents; Drug Interactions; Drug Therapy, Combination; Echinocandins; Fluconazole; Flucytosine; Half-Life; Humans; Itraconazole; Mycoses; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2007 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2007 |
Spondylodiscitis due to an emergent fungal pathogen: Blastoschizomyces capitatus, a case report and review of the literature.
Topics: Aged; Amphotericin B; Antifungal Agents; Dipodascus; Discitis; Fluconazole; Humans; Itraconazole; Ketoconazole; Lumbar Vertebrae; Male; Microbial Sensitivity Tests; Naphthalenes; Opportunistic Infections; Radiography; Terbinafine; Treatment Outcome | 2009 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
Efficacy of fluconazole for the treatment of onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Clinical Trials as Topic; Dose-Response Relationship, Drug; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Systemic drugs in patients with skin diseases.
Topics: Cyclosporine; Fluconazole; Glucocorticoids; Humans; Immunologic Factors; Immunosuppression Therapy; Itraconazole; Methotrexate; Mycophenolic Acid; Naphthalenes; Retinoids; Skin Diseases; Terbinafine | 2011 |
Onychomycosis: modern diagnostic and treatment approaches.
Topics: Antifungal Agents; Candidiasis; Combined Modality Therapy; Dermatomycoses; DNA, Fungal; Enzyme-Linked Immunosorbent Assay; Fluconazole; Humans; Itraconazole; Lasers, Solid-State; Low-Level Light Therapy; Naphthalenes; Onychomycosis; Opportunistic Infections; Polymerase Chain Reaction; Risk Factors; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Terbinafine; Tinea | 2013 |
Oral therapy for onychomycosis: an evidence-based review.
Topics: Administration, Oral; Antifungal Agents; Clinical Trials as Topic; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2014 |
Systemic antifungal therapy for tinea capitis in children.
Topics: Antifungal Agents; Child; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Naphthalenes; Randomized Controlled Trials as Topic; Terbinafine; Tinea Capitis | 2016 |
Onychomycosis in children. A review.
Topics: Administration, Oral; Administration, Topical; Adolescent; Antifungal Agents; Child; Child, Preschool; Fluconazole; Humans; Infant; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 2017 |
The Current Status of Feline Sporotrichosis in Malaysia.
Topics: Amphotericin B; Animals; Antifungal Agents; Cat Diseases; Cats; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Malaysia; Naphthalenes; Prevalence; Sporothrix; Sporotrichosis; Terbinafine; Zoonoses | 2017 |
Tinea capitis in children: a systematic review of management.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Child; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microsporum; Specimen Handling; Terbinafine; Tinea Capitis; Trichophyton | 2018 |
Onychomycosis: Treatment and prevention of recurrence.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Fluconazole; Humans; Itraconazole; Laser Therapy; Nanoparticles; Onychomycosis; Photochemotherapy; Plasma Gases; Prognosis; Pulse Therapy, Drug; Risk Factors; Secondary Prevention; Severity of Illness Index; Terbinafine; Triazoles | 2019 |
The efficacy and safety of pulse vs. continuous therapy for dermatophyte toenail onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Fluconazole; Humans; Itraconazole; Onychomycosis; Terbinafine; Treatment Outcome | 2020 |
Conventional and natural compounds for the treatment of dermatophytosis.
Topics: Antifungal Agents; Arthrodermataceae; Biological Products; Chitosan; Dermatomycoses; Fluconazole; Hair; Humans; Nails; Oils, Volatile; Skin; Terbinafine | 2020 |
Onychomycosis: a review.
Topics: Administration, Topical; Antifungal Agents; Fluconazole; Humans; Itraconazole; Onychomycosis; Terbinafine | 2020 |
The emergence of Trichophyton indotineae: Implications for clinical practice.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Terbinafine; Trichophyton | 2023 |
10 trial(s) available for fluconazole and terbinafine
| Article | Year |
|---|---|
Fluconazole, but not terbinafine, enhances the effects of triazolam by inhibiting its metabolism.
Topics: Administration, Oral; Adult; Analysis of Variance; Antifungal Agents; Cross-Over Studies; Double-Blind Method; Drug Interactions; Female; Fluconazole; Humans; Hypnotics and Sedatives; Male; Naphthalenes; Terbinafine; Triazolam | 1996 |
A double-blind, randomized study to compare the efficacy and safety of terbinafine (Lamisil) with fluconazole (Diflucan) in the treatment of onychomycosis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Double-Blind Method; Fluconazole; Humans; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome | 2000 |
Antifungal susceptibilities and genetic relatedness of serial Trichophyton rubrum isolates from patients with onychomycosis of the toenail.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Foot Dermatoses; Griseofulvin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Polymerase Chain Reaction; Random Amplified Polymorphic DNA Technique; Terbinafine; Trichophyton | 1999 |
Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
Topics: Adult; Antifungal Agents; Female; Fluconazole; Follow-Up Studies; Foot Dermatoses; Gastrointestinal Diseases; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Mitosporic Fungi; Naphthalenes; Nausea; Onychomycosis; Photosensitivity Disorders; Prospective Studies; Single-Blind Method; Terbinafine; Treatment Outcome; Vomiting | 2001 |
Cost effectiveness of oral terbinafine (Lamisil) compared with oral fluconazole (Diflucan) in the treatment of patients with toenail onychomycosis.
Topics: Administration, Oral; Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Double-Blind Method; Female; Fluconazole; Foot Dermatoses; Humans; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
An open, randomized, comparative study of oral fluconazole, itraconazole and terbinafine therapy in onychomycosis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Female; Fluconazole; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
Treatment of tinea imbricata: a randomized clinical trial using griseofulvin, terbinafine, itraconazole and fluconazole.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Child; Female; Fluconazole; Griseofulvin; Humans; Itraconazole; Male; Middle Aged; Naphthalenes; Prospective Studies; Skin; Terbinafine; Tinea; Treatment Outcome | 2004 |
Comparative evaluation of griseofulvin, terbinafine and fluconazole in the treatment of tinea capitis.
Topics: Antifungal Agents; Child; Cross-Sectional Studies; Female; Fluconazole; Griseofulvin; Humans; Male; Naphthalenes; Terbinafine; Tinea Capitis; Trichophyton | 2012 |
Treatment of Onychomycosis - a Clinical Study.
Topics: Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pulse Therapy, Drug; Pyridones; Terbinafine | 2015 |
Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Naphthalenes; Pharmaceutical Preparations; Terbinafine; Tinea | 2020 |
123 other study(ies) available for fluconazole and terbinafine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structure-based optimization of azole antifungal agents by CoMFA, CoMSIA, and molecular docking.
Topics: Antifungal Agents; Azoles; Binding Sites; Databases, Factual; Fungi; Hydrogen Bonding; In Vitro Techniques; Microbial Sensitivity Tests; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship | 2006 |
Targeting the calcineurin pathway enhances ergosterol biosynthesis inhibitors against Trichophyton mentagrophytes in vitro and in a human skin infection model.
Topics: Antifungal Agents; Calcineurin; Colony Count, Microbial; Culture Media; Cyclosporine; Drug Synergism; Drug Therapy, Combination; Ergosterol; Fluconazole; Humans; Immunosuppressive Agents; Naphthalenes; Signal Transduction; Skin; Tacrolimus; Terbinafine; Tinea; Trichophyton | 2007 |
Synthesis and antifungal activities of novel 2-aminotetralin derivatives.
Topics: Administration, Intravaginal; Animals; Antifungal Agents; Binding Sites; Candida albicans; Candidiasis; Cytochrome P-450 Enzyme System; Drug Resistance, Fungal; Female; Fluconazole; Microbial Sensitivity Tests; Models, Molecular; Oxidoreductases; Protein Binding; Rats; Sterol 14-Demethylase; Structure-Activity Relationship; Tetrahydronaphthalenes; Vaginal Diseases | 2007 |
Antifungal and cytotoxic activities of some N-substituted aniline derivatives bearing a hetaryl fragment.
Topics: Aniline Compounds; Antifungal Agents; Antineoplastic Agents; Drug Screening Assays, Antitumor; Humans; Imines; Microbial Sensitivity Tests; Molecular Structure; National Cancer Institute (U.S.); United States | 2008 |
In vitro antifungal susceptibilities of five species of sporothrix.
Topics: Animals; Antifungal Agents; Drug Resistance, Fungal; Humans; Microbial Sensitivity Tests; Species Specificity; Sporothrix; Sporotrichosis | 2008 |
Potent in vitro antifungal activities of naturally occurring acetylenic acids.
Topics: Alkynes; Animals; Antifungal Agents; Candida albicans; Cell Line; Fatty Acids, Unsaturated; Fungi; Humans; Mice; Microbial Sensitivity Tests; Molecular Structure; Plants, Medicinal; Rubiaceae; Trichophyton | 2008 |
Synthesis and SAR studies of biaryloxy-substituted triazoles as antifungal agents.
Topics: Antifungal Agents; Candida albicans; Fluconazole; Humans; Microbial Sensitivity Tests; Molecular Structure; Pyrimidines; Structure-Activity Relationship; Triazoles; Voriconazole; Yeasts | 2008 |
Abc1p is a multidrug efflux transporter that tips the balance in favor of innate azole resistance in Candida krusei.
Topics: Amino Acid Sequence; Animals; Antifungal Agents; ATP-Binding Cassette Transporters; Azoles; Blotting, Northern; Blotting, Southern; Candida; Candidiasis; Cell Membrane; Chromosomes, Fungal; Drug Resistance, Fungal; Endoplasmic Reticulum; Humans; Phenotype; Plasmids; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae | 2009 |
Design, synthesis, and biological evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: Antifungal Agents; Aspergillus fumigatus; Cytochrome P-450 Enzyme Inhibitors; Drug Design; Enzyme Inhibitors; Protein Binding; Sterol 14-Demethylase; Structure-Activity Relationship; Triazoles | 2009 |
Design, synthesis, and biological evaluation of novel 1-(1H-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-substituted benzylamino-2-propanols.
Topics: Antifungal Agents; Catalytic Domain; Chemistry, Pharmaceutical; Computer Simulation; Crystallography, X-Ray; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Drug Design; Fluconazole; Fungal Proteins; Microbial Sensitivity Tests; Models, Chemical; Propanols; Protein Binding; Triazoles | 2009 |
In vitro activity of thimerosal against ocular pathogenic fungi.
Topics: Alternaria; Amphotericin B; Antifungal Agents; Aspergillus; Eye Infections, Fungal; Fungi; Fusarium; Humans; Microbial Sensitivity Tests; Natamycin; Thimerosal | 2010 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Synthesis and antifungal evaluation of novel triazole derivatives as inhibitors of cytochrome P450 14alpha-demethylase.
Topics: 14-alpha Demethylase Inhibitors; Antifungal Agents; Fungi; Humans; Models, Molecular; Mycoses; Sterol 14-Demethylase; Triazoles | 2010 |
Analysis of physico-chemical properties of substrates of ABC and MFS multidrug transporters of pathogenic Candida albicans.
Topics: Candida albicans; Membrane Transport Proteins; Saccharomyces cerevisiae; Structure-Activity Relationship; Substrate Specificity | 2010 |
Synthesis and antifungal activity of some substituted phenothiazines and related compounds.
Topics: Antifungal Agents; Drug Discovery; Fungi; Microbial Sensitivity Tests; Phenothiazines; Structure-Activity Relationship | 2011 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.
Topics: Antifungal Agents; Candida albicans; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Liver; Models, Molecular; Nitriles; Protein Conformation; Saccharomyces cerevisiae; Sterol 14-Demethylase; User-Computer Interface | 2012 |
Solution-phase microwave assisted parallel synthesis of N,N'-disubstituted thioureas derived from benzoic acid: biological evaluation and molecular docking studies.
Topics: Antifungal Agents; Antioxidants; Aspergillus; Benzoic Acid; Candida tropicalis; Dose-Response Relationship, Drug; Enzyme Inhibitors; Microbial Sensitivity Tests; Microwaves; Models, Molecular; Molecular Structure; Saccharomyces cerevisiae; Solutions; Structure-Activity Relationship; Thiourea; Urease | 2013 |
Synthesis, antifungal activities and molecular docking studies of novel 2-(2,4-difluorophenyl)-2-hydroxy-3-(1H-1,2,4-triazol-1-yl)propyl dithiocarbamates.
Topics: Aspergillus fumigatus; Candida; Carbamates; Magnetic Resonance Spectroscopy; Mass Spectrometry; Microbial Sensitivity Tests; Molecular Docking Simulation | 2014 |
Polyhydroxy cyclohexanols from a Dendrodochium sp. fungus associated with the sea cucumber Holothuria nobilis Selenka.
Topics: Animals; Antifungal Agents; Cryptococcus neoformans; Cyclohexanols; Holothuria; Humans; Microbial Sensitivity Tests; Molecular Structure; Oceans and Seas; Trichophyton | 2014 |
2-(2-oxo-morpholin-3-yl)-acetamide derivatives as broad-spectrum antifungal agents.
Topics: Acetamides; Animals; Antifungal Agents; Candida; Candidiasis; Disease Models, Animal; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Molecular Structure; Morpholines; Species Specificity; Structure-Activity Relationship; Substrate Specificity | 2015 |
Heptaketides from an Endolichenic Fungus Biatriospora sp. and Their Antifungal Activity.
Topics: Antifungal Agents; Ascomycota; ATP-Binding Cassette Transporters; Candida albicans; Drug Resistance, Fungal; Fluconazole; Lichens; Microbial Sensitivity Tests; Molecular Structure; Nuclear Magnetic Resonance, Biomolecular; Polyketides | 2016 |
Efficiency of newly prepared thiazole derivatives against some cutaneous fungi.
Topics: Animals; Antifungal Agents; Binding Sites; Candida albicans; Fluconazole; Fungal Proteins; Guinea Pigs; Hydrogen Bonding; Microbial Sensitivity Tests; Microsporum; Molecular Docking Simulation; Peptide Hydrolases; Protein Structure, Tertiary; Skin Diseases; Structure-Activity Relationship; Thiazoles; Trichophyton | 2018 |
Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors.
Topics: Amides; Antifungal Agents; Binding Sites; Candida albicans; Catalytic Domain; Drug Design; Fungal Proteins; Microbial Sensitivity Tests; Molecular Docking Simulation; Protein Binding; Pyridines; Quantitative Structure-Activity Relationship; Squalene Monooxygenase; Sterol 14-Demethylase | 2019 |
A new sulfated triterpene glycoside from the sea cucumber Colochirus quadrangularis, and evaluation of its antifungal, antitumor and immunomodulatory activities.
Topics: Animals; Antifungal Agents; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Glycosides; Humans; Immunomodulation; Mice; Mice, Nude; Molecular Structure; Neoplasms, Experimental; Saponins; Sea Cucumbers; Triterpenes | 2021 |
Optimization and Evaluation of Novel Antifungal Agents for the Treatment of Fungal Infection.
Topics: Animals; Antifungal Agents; Cell Wall; Drug Evaluation, Preclinical; Drug Synergism; Female; Fungi; Humans; Male; Mice; Microbial Sensitivity Tests; Mycoses; Rats, Sprague-Dawley | 2021 |
New antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Dermatomycoses; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Terbinafine | 1992 |
Comparative effects of the antimycotic drugs ketoconazole, fluconazole, itraconazole and terbinafine on the metabolism of cyclosporin by human liver microsomes.
Topics: Adult; Antifungal Agents; Cyclosporine; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Microsomes, Liver; Naphthalenes; Terbinafine | 1991 |
[Treatment of mycoses and new antifungal agents].
Topics: Allylamine; Amphotericin B; Antifungal Agents; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Miconazole; Mycoses; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine | 1989 |
The new generation of antifungal drugs.
Topics: Antifungal Agents; Echinocandins; Fluconazole; Humans; Itraconazole; Ketoconazole; Naphthalenes; Peptides; Peptides, Cyclic; Terbinafine; Triazoles | 1988 |
Effects of bifonazole, fluconazole, itraconazole, and terbinafine on the chemiluminescence response of immune cells.
Topics: Animals; Antifungal Agents; Cell Survival; Centrifugation; Fluconazole; Imidazoles; In Vitro Techniques; Itraconazole; Ketoconazole; Luminescent Measurements; Luminol; Mice; Mice, Inbred BALB C; Naphthalenes; Phagocytes; Rabbits; Rifampin; Spleen; Terbinafine; Triazoles | 1987 |
The efficacy of orally applied terbinafine, itraconazole and fluconazole in models of experimental trichophytoses.
Topics: Administration, Oral; Animals; Antifungal Agents; Disease Models, Animal; Female; Fluconazole; Guinea Pigs; Hair; Itraconazole; Naphthalenes; Skin Temperature; Terbinafine; Tinea; Treatment Outcome | 1994 |
New drugs for the nail fungus prevalent in elderly.
Topics: Aged; Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
New therapies for onychomycosis.
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1996 |
In vitro activities of terbinafine in combination with fluconazole and itraconazole against isolates of Candida albicans with reduced susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida albicans; Drug Interactions; Drug Therapy, Combination; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1997 |
[How I treat onychomycosis using pulsed therapy].
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Diagnosis, Differential; Drug Administration Schedule; Fluconazole; Humans; Itraconazole; Nail Diseases; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
Contempo 1997: dermatology.
Topics: Antifungal Agents; Contraceptives, Oral; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Onychomycosis; Terbinafine | 1997 |
In-vitro interaction of terbinafine with amphotericin B, fluconazole and itraconazole against clinical isolates of Candida albicans.
Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Drug Synergism; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 1998 |
Successful treatment of fluconazole-resistant oropharyngeal candidiasis by a combination of fluconazole and terbinafine.
Topics: Adult; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Fluconazole; Humans; Naphthalenes; Terbinafine | 1999 |
The use of systemic antimycotics in dermatotherapy.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Cost-Benefit Analysis; Dermatomycoses; Fluconazole; Griseofulvin; Hair Diseases; Humans; Itraconazole; Ketoconazole; Naphthalenes; Odds Ratio; Onychomycosis; Terbinafine; Tinea | 2000 |
An evaluation of the in vitro activity of terbinafine.
Topics: Antifungal Agents; Evaluation Studies as Topic; Fluconazole; Fungi; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2000 |
Comparative efficacies of terbinafine and fluconazole in treatment of experimental coccidioidal meningitis in a rabbit model.
Topics: Animals; Antifungal Agents; Cerebrospinal Fluid; Coccidioides; Coccidioidomycosis; Colony-Forming Units Assay; Disease Models, Animal; Fluconazole; Glucose; Leukocytes; Male; Meningitis, Fungal; Microbial Sensitivity Tests; Naphthalenes; Rabbits; Terbinafine; Treatment Outcome | 2000 |
The implications and management of drug interactions with itraconazole, fluconazole and terbinafine.
Topics: Administration, Oral; Antifungal Agents; Dermatomycoses; Drug Interactions; Fluconazole; Humans; Itraconazole; Naphthalenes; Terbinafine | 2000 |
Synergistic interaction of terbinafine with triazoles or amphotericin B against Aspergillus species.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Aspergillus fumigatus; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2001 |
[Antifungal susceptibility testing in chronically recurrent vaginal candidosis as basis for effective therapy].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Chronic Disease; Ciclopirox; Female; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Pyridones; Pyrimidines; Terbinafine; Triazoles; Vaginitis; Voriconazole | 2000 |
Trichophyton rubrum showing deep dermal invasion directly from the epidermis in immunosuppressed patients.
Topics: Adolescent; Adult; Amphotericin B; Anti-Inflammatory Agents; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Fluconazole; Humans; Immunocompromised Host; Leukemia, Myeloid, Acute; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Naphthalenes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Steroids; Terbinafine; Tinea; Treatment Outcome; Trichophyton | 2001 |
In vitro activities of terbinafine in combination with fluconazole, itraconazole, voriconazole, and posaconazole against clinical isolates of Candida glabrata with decreased susceptibility to azoles.
Topics: Antifungal Agents; Azoles; Candida; Dose-Response Relationship, Drug; Fluconazole; HIV Infections; Humans; Itraconazole; Laboratories; Microbial Sensitivity Tests; Mouth; Naphthalenes; Pyrimidines; Quality Control; Terbinafine; Triazoles; Voriconazole | 2002 |
[Diversified treatments of Tinea unguium].
Topics: Administration, Oral; Antifungal Agents; Combined Modality Therapy; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Occlusive Dressings; Onychomycosis; Pulse Therapy, Drug; Terbinafine | 2002 |
[Pharmacoeconomic approach to onychomycosis therapy].
Topics: Antifungal Agents; Fluconazole; Humans; Itraconazole; Military Personnel; Naphthalenes; Onychomycosis; Terbinafine | 2002 |
In vitro interaction of terbinafine with itraconazole, fluconazole, amphotericin B and 5-flucytosine against Aspergillus spp.
Topics: Amphotericin B; Antifungal Agents; Aspergillus; Drug Interactions; Drug Synergism; Drug Therapy, Combination; Fluconazole; Flucytosine; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2002 |
Tinea capitis in Brussels: epidemiology and new management strategy.
Topics: Adolescent; Antifungal Agents; Belgium; Child; Child, Preschool; Drug Combinations; Female; Fluconazole; Humans; Infant; Itraconazole; Male; Naphthalenes; Prevalence; Retrospective Studies; Terbinafine; Tinea Capitis; Treatment Outcome | 2003 |
Newer antifungal agents.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Humans; Naphthalenes; Terbinafine; Tinea Capitis | 2003 |
In vitro activity of amphotericin B, itraconazole, terbinafine and 5-fluocytosine against Exophiala spinifera and evaluation of post-antifungal effects.
Topics: Amphotericin B; Antifungal Agents; Environmental Microbiology; Exophiala; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine | 2003 |
Cyclic AMP signaling pathway modulates susceptibility of candida species and Saccharomyces cerevisiae to antifungal azoles and other sterol biosynthesis inhibitors.
Topics: Adenylyl Cyclase Inhibitors; Adenylyl Cyclases; Antifungal Agents; Azoles; Candida; Cyclic AMP; Fluconazole; Fungal Proteins; Gene Expression Regulation, Fungal; Genotype; Imines; Itraconazole; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Naphthalenes; Protein Synthesis Inhibitors; Saccharomyces cerevisiae; Signal Transduction; Sterols; Terbinafine; Up-Regulation | 2003 |
[In vitro activity of voriconazole and three other antifungal agents against dermatophytes].
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Pyrimidines; Species Specificity; Terbinafine; Triazoles; Trichophyton; Voriconazole | 2003 |
Skin infection due to Geomyces pannorum var. pannorum.
Topics: Adult; Antifungal Agents; Dermatomycoses; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Italy; Male; Microbial Sensitivity Tests; Naphthalenes; Onygenales; Terbinafine | 2003 |
Pyridines and pyrimidines mediating activity against an efflux-negative strain of Candida albicans through putative inhibition of lanosterol demethylase.
Topics: Antifungal Agents; Candida albicans; Culture Media; Cytochrome P-450 Enzyme Inhibitors; Enzyme Inhibitors; Fluconazole; Genes, Reporter; Microbial Sensitivity Tests; Naphthalenes; Oxidoreductases; Pyridines; Pyrimidines; Sterol 14-Demethylase; Sterols; Terbinafine | 2004 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
[Modern antimycotics. What the treating physician needs to know].
Topics: Antifungal Agents; Arthrodermataceae; Child; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Time Factors | 2004 |
In vitro antifungal activity of sertaconazole compared with nine other drugs against 250 clinical isolates of dermatophytes and Scopulariopsis brevicaulis.
Topics: Antifungal Agents; Arthrodermataceae; Ascomycota; Clotrimazole; Econazole; Fluconazole; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Terbinafine; Thiophenes | 2004 |
Synergistic activities of fluconazole and voriconazole with terbinafine against four Candida species determined by checkerboard, time-kill, and Etest methods.
Topics: Antifungal Agents; Candida; Drug Synergism; Fluconazole; Microbial Sensitivity Tests; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2005 |
[Synthesis and antifungal activity of novel triazole antifungal agents].
Topics: Antifungal Agents; Aspergillus fumigatus; Candida albicans; Cryptococcus neoformans; Fluconazole; Microbial Sensitivity Tests; Molecular Structure; Naphthalenes; Structure-Activity Relationship; Terbinafine; Triazoles | 2004 |
In vitro activities of posaconazole, ravuconazole, terbinafine, itraconazole and fluconazole against dermatophyte, yeast and non-dermatophyte species.
Topics: Antifungal Agents; Arthrodermataceae; Fluconazole; Fungi; Humans; Itraconazole; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Terbinafine; Thiazoles; Triazoles; Yeasts | 2005 |
Comparison of in vitro activities of antifungal drugs and ethanolic extract of propolis against Trichophyton rubrum and T. mentagrophytes by using a microdilution assay.
Topics: Antifungal Agents; Fluconazole; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Propolis; Terbinafine; Trichophyton; Turkey | 2005 |
In vitro susceptibility testing of Microsporum gypseum isolated from healthy cattle and soil samples against itraconazole, terbinafine, fluconazole and topical veterinarian drugs.
Topics: Animals; Anti-Infective Agents, Local; Antifungal Agents; Cattle; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Microsporum; Naphthalenes; Soil Microbiology; Terbinafine; Veterinary Drugs | 2005 |
[Current treatment recommendations in tinea corporis?].
Topics: Antifungal Agents; Clotrimazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Naphthalenes; Terbinafine; Tinea | 2006 |
Antifungal susceptibilities of the species of the Pseudallescheria boydii complex.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Echinocandins; Fluconazole; Flucytosine; Humans; Itraconazole; Ketoconazole; Lipopeptides; Lipoproteins; Micafungin; Microbial Sensitivity Tests; Naphthalenes; Peptides, Cyclic; Pseudallescheria; Pyrimidines; Quality Control; Quinazolines; Scedosporium; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2006 |
In vitro methods for antifungal susceptibility testing of Trichophyton spp.
Topics: Antifungal Agents; Fluconazole; Griseofulvin; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine; Trichophyton | 2006 |
Evaluation of susceptibility of Trichophyton mentagrophytes and Trichophyton rubrum clinical isolates to antifungal drugs using a modified CLSI microdilution method (M38-A).
Topics: Antifungal Agents; Dose-Response Relationship, Drug; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 2007 |
Analysis of Trichophyton rubrum gene expression in response to cytotoxic drugs.
Topics: Antifungal Agents; Blotting, Northern; DNA, Complementary; Expressed Sequence Tags; Fatty Acids; Fluconazole; Gene Expression Regulation, Fungal; Genes, Fungal; Griseofulvin; Molecular Sequence Data; Naphthalenes; Nucleic Acid Hybridization; Sequence Analysis, DNA; Terbinafine; Trichophyton | 2007 |
Onychocryptosis as consequence of effective treatment of dermatophytic onychomycosis.
Topics: Administration, Oral; Antifungal Agents; Drug Therapy, Combination; Fluconazole; Humans; Itraconazole; Nails, Ingrown; Naphthalenes; Onychomycosis; Retrospective Studies; Terbinafine; Treatment Outcome | 2007 |
Comparison of the effects of three different anti-fungus drugs on Candida albicans of murine vaginal mucosa.
Topics: Animals; Antifungal Agents; Candidiasis, Vulvovaginal; Female; Fluconazole; Itraconazole; Mice; Mice, Inbred ICR; Naphthalenes; Random Allocation; Terbinafine; Treatment Outcome; Vagina | 2007 |
Identification and in vitro antifungal susceptibility testing of 200 clinical isolates of Candida spp. responsible for fingernail infections.
Topics: Antifungal Agents; Brazil; Candida; Candidiasis; Ciclopirox; Fluconazole; Hand Dermatoses; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2007 |
Fusarium spp. as agents of onychomycosis in immunocompetent hosts.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Brazil; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Immunocompetence; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nails; Naphthalenes; Onychomycosis; Terbinafine | 2007 |
In vitro antifungal susceptibility patterns of dermatophyte strains causing tinea unguium.
Topics: Adult; Antifungal Agents; Dose-Response Relationship, Drug; Drug Evaluation; Drug Resistance, Fungal; Female; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Terbinafine; Trichophyton | 2007 |
In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Fluconazole; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Thiophenes; Yeasts | 2008 |
In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients.
Topics: Amphotericin B; Antifungal Agents; Corneal Diseases; Drug Evaluation; Drug Synergism; Eye; Eye Infections, Fungal; Fluconazole; Fusarium; Humans; In Vitro Techniques; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Natamycin; Terbinafine | 2008 |
In vitro activity of fluconazole, itraconazole, voriconazole and terbinafine against fungi causing onychomycosis.
Topics: Analysis of Variance; Antifungal Agents; Arthrodermataceae; Candida; Colombia; Dose-Response Relationship, Drug; Fluconazole; Fungi; Fusarium; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2010 |
Screening of antimycotics in Swedish sewage treatment plants--waters and sludge.
Topics: Antifungal Agents; Clotrimazole; Econazole; Environmental Monitoring; Fluconazole; Ketoconazole; Miconazole; Naphthalenes; Sewage; Sweden; Terbinafine; Waste Disposal, Fluid; Water Pollutants, Chemical | 2010 |
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine | 2010 |
Tinea capitis outbreak in a paediatric refugee population, Tel Aviv, Israel.
Topics: Antifungal Agents; Child; Child, Preschool; Disease Outbreaks; Female; Fluconazole; Griseofulvin; Humans; Israel; Male; Microsporum; Mycological Typing Techniques; Naphthalenes; RNA, Ribosomal, 28S; Terbinafine; Tinea Capitis | 2012 |
In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Topics: Animals; Antifungal Agents; Dermatomycoses; Dog Diseases; Dogs; Fluconazole; Itraconazole; Ketoconazole; Malassezia; Miconazole; Naphthalenes; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Entomophthoromycosis caused by Basidiobolus ranarum in tropical northern Australia.
Topics: Antifungal Agents; Australia; Child, Preschool; Drug Therapy, Combination; Entomophthorales; Fluconazole; Humans; Male; Middle Aged; Naphthalenes; Terbinafine; Treatment Outcome; Tropical Climate; Zygomycosis | 2012 |
Identification of yeast genes that confer resistance to chitosan oligosaccharide (COS) using chemogenomics.
Topics: Amphotericin B; Antifungal Agents; Cell Membrane Permeability; Chitosan; Drug Resistance, Fungal; Fluconazole; Gene Expression Profiling; Gene Expression Regulation, Fungal; Haploinsufficiency; Monomeric GTP-Binding Proteins; Naphthalenes; Oxidative Stress; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Terbinafine; Vesicular Transport Proteins | 2012 |
Treatment outcomes for tinea capitis in a skin of color population.
Topics: Adolescent; Age Factors; Antifungal Agents; Black or African American; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Fluconazole; Follow-Up Studies; Griseofulvin; Hispanic or Latino; Humans; Infant; Itraconazole; Male; Naphthalenes; New York City; Retrospective Studies; Terbinafine; Tinea Capitis; Treatment Outcome; Urban Population; White People | 2012 |
Terbinafine inhibits Cryptococcus neoformans growth and modulates fungal morphology.
Topics: Amphotericin B; Antifungal Agents; Cryptococcus neoformans; Drug Synergism; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Naphthalenes; Terbinafine | 2012 |
In vitro activities of nine antifungal drugs against 81 Phialophora and Cyphellophora isolates.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Echinocandins; Fluconazole; Itraconazole; Lipopeptides; Micafungin; Microbial Sensitivity Tests; Mitosporic Fungi; Naphthalenes; Nitriles; Phialophora; Pyridines; Pyrimidines; Terbinafine; Triazoles; Voriconazole | 2012 |
Pityriasis versicolor: a case of resistance to treatment.
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Humans; Imidazoles; Itraconazole; Ketoconazole; Male; Middle Aged; Naphthalenes; Recurrence; Terbinafine; Tinea Versicolor; Treatment Failure | 2014 |
Trichophyton mentagrophytes cause underestimated contagious zoophilic fungal infection.
Topics: Administration, Oral; Administration, Topical; Adult; Animals; Anti-Inflammatory Agents; Antifungal Agents; Child; Child, Preschool; Diflucortolone; Environmental Exposure; Family Health; Female; Fluconazole; Humans; Male; Miconazole; Naphthalenes; Pets; Terbinafine; Tinea; Treatment Outcome; Trichophyton | 2013 |
Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans.
Topics: Antifungal Agents; Candida albicans; Cell Membrane; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Gene Expression Regulation, Fungal; Humans; Microbial Sensitivity Tests; Naphthalenes; Reverse Transcriptase Polymerase Chain Reaction; Terbinafine | 2014 |
Caenorhabditis elegans: a simple nematode infection model for Penicillium marneffei.
Topics: Amphotericin B; Animals; Antifungal Agents; Caenorhabditis elegans; Disease Models, Animal; Fluconazole; Host-Pathogen Interactions; Hyphae; Itraconazole; Mycoses; Naphthalenes; Penicillium; Pigments, Biological; Survival Analysis; Terbinafine; Voriconazole | 2014 |
In vitro susceptibility patterns of clinically important Trichophyton and Epidermophyton species against nine antifungal drugs.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Caspofungin; Echinocandins; Epidermophyton; Fluconazole; Humans; Itraconazole; Lipopeptides; Microbial Sensitivity Tests; Naphthalenes; Nitriles; Pyridines; Terbinafine; Tinea; Triazoles; Trichophyton; Voriconazole | 2015 |
Fusarium spp. is able to grow and invade healthy human nails as a single source of nutrients.
Topics: Antifungal Agents; Cross-Sectional Studies; Fluconazole; Fusariosis; Fusarium; Humans; Keratins; Microbial Sensitivity Tests; Naphthalenes; Onychomycosis; Retrospective Studies; Terbinafine | 2015 |
In vitro activity of the protegrin IB-367 alone and in combination compared with conventional antifungal agents against dermatophytes.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Arthrodermataceae; Colony Count, Microbial; Dermatomycoses; Drug Synergism; Fluconazole; Humans; Hyphae; Itraconazole; Microbial Sensitivity Tests; Microbial Viability; Naphthalenes; Terbinafine | 2014 |
Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
Topics: Antifungal Agents; Candida albicans; Ciclopirox; Epidermophyton; Fluconazole; Hand Dermatoses; Humans; Keratins; Microbial Sensitivity Tests; Morpholines; Nails; Naphthalenes; Onychomycosis; Pyridones; Spores, Fungal; Terbinafine; Trichophyton | 2015 |
Antifungal Drugs for Onychomycosis: Efficacy, Safety, and Mechanisms of Action.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Treatment Outcome; Triazoles; United States | 2016 |
Evaluation of antifungal combination against Cryptococcus spp.
Topics: Amphotericin B; Antifungal Agents; Brazil; Cryptococcosis; Cryptococcus; Cryptococcus neoformans; Drug Combinations; Drug Synergism; Fluconazole; Flucytosine; Genotype; Humans; Itraconazole; Microbial Sensitivity Tests; Molecular Typing; Naphthalenes; Polymorphism, Restriction Fragment Length; Terbinafine; Voriconazole | 2016 |
Susceptibility to antifungal agents and enzymatic activity of Candida haemulonii and Cutaneotrichosporon dermatis isolated from soft corals on the Brazilian reefs.
Topics: Animals; Anthozoa; Antifungal Agents; Basidiomycota; Brazil; Candida; DNA, Ribosomal; Drug Resistance, Multiple, Fungal; Esterases; Fluconazole; Gelatinases; Humans; Imidazoles; Microbial Sensitivity Tests; Naphthalenes; Sequence Analysis, DNA; Terbinafine; Triazoles | 2016 |
A Case Report of Penile Infection Caused by Fluconazole- and Terbinafine-Resistant Candida albicans.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Microbiological Techniques; Molecular Diagnostic Techniques; Naphthalenes; Penile Diseases; Recurrence; Terbinafine; Treatment Outcome | 2017 |
Prevalence and epidemiology of tinea pedis and toenail onychomycosis and antifungal susceptibility of the causative agents in patients with type 2 diabetes in Turkey.
Topics: Adult; Age Factors; Aged; Antifungal Agents; Arthrodermataceae; Case-Control Studies; Diabetes Mellitus, Type 2; Female; Fluconazole; Glycated Hemoglobin; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Naphthalenes; Onychomycosis; Prevalence; Sex Factors; Terbinafine; Tinea Pedis; Toes; Trichophyton; Turkey | 2017 |
In vitro synergism of a water insoluble fraction of Uncaria tomentosa combined with fluconazole and terbinafine against resistant non-Candida albicans isolates.
Topics: Antifungal Agents; Calorimetry, Differential Scanning; Candida; Cat's Claw; Cell Wall; Drug Resistance, Fungal; Drug Synergism; Fluconazole; Microscopy, Electron, Scanning; Naphthalenes; Phytotherapy; Plant Bark; Plant Extracts; Plants, Medicinal; Solubility; Spectroscopy, Fourier Transform Infrared; Terbinafine; Water | 2017 |
In vitro inhibitory effects of farnesol and interactions between farnesol and antifungals against biofilms of Candida albicans resistant strains.
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida albicans; Caspofungin; Drug Interactions; Drug Resistance, Fungal; Echinocandins; Farnesol; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Microscopy, Electron, Scanning; Naphthalenes; Terbinafine | 2017 |
Synthetic antimicrobial peptides of the halictines family disturb the membrane integrity of Candida cells.
Topics: Amphotericin B; Anti-Infective Agents; Antifungal Agents; Candida; Cell Membrane; Fatty Acids, Monounsaturated; Fluconazole; Imines; Lipids; Microbial Sensitivity Tests; Naphthalenes; Peptides; Pyridines; Sterols; Terbinafine | 2017 |
Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis.
Topics: Amphotericin B; Antifungal Agents; Female; Fluconazole; Fusariosis; Fusarium; Genetic Variation; Humans; Itraconazole; Microbial Sensitivity Tests; Nails; Naphthalenes; Onychomycosis; Terbinafine; Voriconazole | 2017 |
Pulsed electric field-assisted sensitization of multidrug-resistant Candida albicans to antifungal drugs.
Topics: Allylamine; Antifungal Agents; Biofilms; Candida albicans; Cell Membrane Permeability; Drug Resistance, Multiple, Fungal; Electric Stimulation; Electrochemical Techniques; Fluconazole; Humans; Hydrogen-Ion Concentration; Naphthalenes; Propidium; Terbinafine | 2018 |
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Ciclopirox; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Morpholines; Squalene Monooxygenase; Terbinafine; Trichophyton; Voriconazole | 2018 |
Diversity of phenotypically non-dermatophyte, non-Aspergillus filamentous fungi causing nail infections: importance of accurate identification and antifungal susceptibility testing.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Biodiversity; Child; Child, Preschool; Female; Fluconazole; Fungi; Hong Kong; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Nail Diseases; Onychomycosis; Phenotype; Phylogeny; Terbinafine; Young Adult | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |
Comparison of in vitro antifungal activity of novel triazoles with available antifungal agents against dermatophyte species caused tinea pedis.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Ketoconazole; Microbial Sensitivity Tests; Terbinafine; Tinea; Tinea Pedis; Triazoles; Trichophyton; Voriconazole | 2020 |
In vitro antifungal susceptibility of Sporothrix globosa isolates from Jilin Province, northeastern China: comparison of yeast and mycelial phases.
Topics: Amphotericin B; Antifungal Agents; China; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Mycelium; Phylogeny; Saccharomyces cerevisiae; Sporothrix; Sporotrichosis; Terbinafine; Triazoles | 2021 |
A call for antifungal stewardship.
Topics: Antifungal Agents; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical Preparations; Terbinafine; Tinea | 2020 |
The science and rationale of arriving at the correct drug and dosimetry of griseofulvin, fluconazole, terbinafine and itraconazole in superficial dermatophyte infections: an important step before a pragmatic trial.
Topics: Antifungal Agents; Arthrodermataceae; Epidemics; Fluconazole; Griseofulvin; Humans; India; Itraconazole; Pharmaceutical Preparations; Terbinafine | 2021 |
A Retrospective Study of Tinea Capitis Management in General Pediatric Clinics and Pediatric Emergency Departments at 2 US Centers.
Topics: Academic Medical Centers; Adolescent; Antifungal Agents; Child; Child, Preschool; Cross-Sectional Studies; Emergency Service, Hospital; Female; Fluconazole; Griseofulvin; Humans; Male; Pediatrics; Practice Patterns, Physicians'; Retrospective Studies; Terbinafine; Tinea Capitis; United States | 2021 |
Nannizzia incurvata in Hue city - Viet Nam: Molecular identification and antifungal susceptibility testing.
Topics: Antifungal Agents; Arthrodermataceae; DNA, Ribosomal; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Lipase; Microbial Sensitivity Tests; Peptide Hydrolases; Phospholipases; Phylogeny; Terbinafine; Tinea; Vietnam; Voriconazole | 2022 |
In vitro activity of 23 antifungal drugs against 54 clinical and environmental Aspergillus oryzae isolates.
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Aspergillus oryzae; Clotrimazole; Econazole; Fluconazole; Griseofulvin; Humans; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Natamycin; Nystatin; Terbinafine; Tolnaftate; Voriconazole | 2022 |
High MICs for antifungal agents in yeasts from an anthropized lagoon in South America.
Topics: Amphotericin B; Antifungal Agents; Drug Resistance, Fungal; Ecosystem; Fluconazole; Microbial Sensitivity Tests; Pesticides; Tandem Mass Spectrometry; Terbinafine; Yeasts | 2022 |
PULMONARY AND COELOMIC MYCOSES DUE TO
Topics: Alligators and Crocodiles; Animals; Beauveria; Fluconazole; Itraconazole; Metarhizium; Mycoses; Pest Control, Biological; Terbinafine; Turtles; Voriconazole | 2022 |
Malassezia spp. and Candida spp. from patients with psoriasis exhibit reduced susceptibility to antifungals.
Topics: Amphotericin B; Antifungal Agents; Candida; Cross-Sectional Studies; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Malassezia; Microbial Sensitivity Tests; Psoriasis; Saccharomyces cerevisiae; Terbinafine | 2023 |
Comparison of in vitro activities of newer triazoles and classic antifungal agents against dermatophyte species isolated from Iranian University Hospitals: a multi-central study.
Topics: Antifungal Agents; Arthrodermataceae; Caspofungin; Fluconazole; Griseofulvin; Hospitals, University; Humans; Iran; Itraconazole; Terbinafine; Triazoles | 2023 |
Inadequate diagnostic testing and systemic antifungal prescribing for tinea capitis in an observational cohort study of 3.9 million children, United States.
Topics: Antifungal Agents; Child; Cohort Studies; Fluconazole; Humans; Itraconazole; Terbinafine; Tinea Capitis; United States | 2023 |
The rising menace of antifungal resistance in dermatophytes among the patients of tinea capitis.
Topics: Antifungal Agents; Child; Cross-Sectional Studies; Female; Fluconazole; Humans; Male; Terbinafine; Tinea Capitis | 2023 |